Viewing Study NCT03018093


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-05-18 @ 4:12 AM
Study NCT ID: NCT03018093
Status: UNKNOWN
Last Update Posted: 2017-01-20
First Post: 2017-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL
Sponsor: Shanghai AbelZeta Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed or refractory acute lymphoblastic leukemia View
None Anti-CD19 chimeric antigen receptor T-cell View